tetano
Editor, Senior Moderator
Influenza Other Respir Viruses
. 2026 Sep;20(9):e70304.
doi: 10.1111/irv.70304.
Diana Toledo 1 2 , Núria Soldevila 1 2 , Juan Carlos Galan 2 3 , Pere Godoy 2 4 , María Morales-Suarez-Varela 2 5 , Marta Rodriguez-Suárez 6 7 , María Grau 1 2 , Tania Fernández-Villa 2 8 , Aurea Morillo 9 , Gemma Navarro 10 , Judith Chamorro 11 , Angela Domínguez 1 2 ; Project PI19/00354 Working Group
Collaborators, Affiliations
Background: Seasonal influenza, especially in persons with underlying medical conditions, is a substantial global burden. Influenza vaccination effectiveness (VE) varies annually, requiring continuous evaluation due to evolving viruses and vaccination coverages. Our aim was to investigate influenza VE in preventing hospitalization for confirmed influenza among people aged 15-64 years with underlying medical conditions.
Methods: We conducted a multicentre case-control study across 17 Spanish hospitals in hospitalized patients aged 15-64 years with underlying medical conditions in three influenza seasons. Influenza VE was estimated using two types of controls: test-negative controls and non-acute respiratory infection controls. Data on demographics, underlying medical conditions, vaccination status and clinical outcomes were collected. Adjusted VE was analysed using multivariable logistic regression models.
Results: Recruited were 1220 hospitalized adults with underlying medical conditions, of whom 25.2% were vaccinated. VE varied by season, age group, and virus subtype. Statistically significant protection was observed for all seasons jointly against influenza A(H3N2) subtype, whereas VE estimates for specific seasons and subtypes were not significant.
Conclusions: These findings underscore the importance of continuous VE monitoring and tailored vaccination strategies to protect adults with underlying medical conditions and highlight low seasonal influenza vaccination coverage in this population. Influenza seasonal vaccination should be improved in people aged 15-64 years with underlying medical conditions.
Keywords: adults; hospitalised cases; hospitalised controls; influenza; underlying medical condition; vaccination effectiveness.
. 2026 Sep;20(9):e70304.
doi: 10.1111/irv.70304.
Influenza Vaccination Effectiveness in Preventing Hospitalization of Adults With Underlying Medical Conditions: A Multicentre Case-Control Study
Diana Toledo 1 2 , Núria Soldevila 1 2 , Juan Carlos Galan 2 3 , Pere Godoy 2 4 , María Morales-Suarez-Varela 2 5 , Marta Rodriguez-Suárez 6 7 , María Grau 1 2 , Tania Fernández-Villa 2 8 , Aurea Morillo 9 , Gemma Navarro 10 , Judith Chamorro 11 , Angela Domínguez 1 2 ; Project PI19/00354 Working Group
Collaborators, Affiliations
- PMID: 42693773
- DOI: 10.1111/irv.70304
Abstract
Background: Seasonal influenza, especially in persons with underlying medical conditions, is a substantial global burden. Influenza vaccination effectiveness (VE) varies annually, requiring continuous evaluation due to evolving viruses and vaccination coverages. Our aim was to investigate influenza VE in preventing hospitalization for confirmed influenza among people aged 15-64 years with underlying medical conditions.
Methods: We conducted a multicentre case-control study across 17 Spanish hospitals in hospitalized patients aged 15-64 years with underlying medical conditions in three influenza seasons. Influenza VE was estimated using two types of controls: test-negative controls and non-acute respiratory infection controls. Data on demographics, underlying medical conditions, vaccination status and clinical outcomes were collected. Adjusted VE was analysed using multivariable logistic regression models.
Results: Recruited were 1220 hospitalized adults with underlying medical conditions, of whom 25.2% were vaccinated. VE varied by season, age group, and virus subtype. Statistically significant protection was observed for all seasons jointly against influenza A(H3N2) subtype, whereas VE estimates for specific seasons and subtypes were not significant.
Conclusions: These findings underscore the importance of continuous VE monitoring and tailored vaccination strategies to protect adults with underlying medical conditions and highlight low seasonal influenza vaccination coverage in this population. Influenza seasonal vaccination should be improved in people aged 15-64 years with underlying medical conditions.
Keywords: adults; hospitalised cases; hospitalised controls; influenza; underlying medical condition; vaccination effectiveness.